Skip to main content
Premium Trial:

Request an Annual Quote

GeneNews Raises $6.7M in Private Placement

NEW YORK (GenomeWeb) – GeneNews today announced it has accepted subscriptions for a non-brokered private placement of its common shares for gross proceeds of about C$7.2 million (US$6.7 million).

The Toronto-based molecular diagnostics shop will issue 7 million common shares at C$1.03 per share as a result of the placement, which GeneNews announced last week. In a statement, GeneNews Executive Chairman James Howard-Tripp said that the financing provides the company with the resources to build out Innovative Diagnostics Laboratory "as a strong commercialization outlet" for the firm's molecular diagnostic tests for colon cancer, lung cancer, and prostate cancer.

IDL is a CLIA laboratory jointly owned by GeneNews, Health Diagnostics Laboratory, and an unnamed US sales organization.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.